3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
31
Hodgkin Disease
19
Lymphoma
9
Uveal Melanoma
5
Neoplasms
4
Sarcoma
3
Neoplasm Metastasis
3
Leiomyosarcoma
3
Skin Neoplasms
2
Skin Diseases
1
Sarcoma, Synovial
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neurofibrosarcoma
1
Lymphoma, T-Cell, Peripheral
1
Hematologic Diseases
1
HIV Infections
1
Interventions
pazopanib
2
Radiotherapy
2
Ifosfamide
2
Doxorubicin
2
romidepsin
1
indolepropanol phosphate
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiation
1
Polymerase Chain Reaction
1
Observation
1
Neoadjuvant Therapy
1
HhAntag691
1
Gene Expression Profiling
1
Gemcitabine
1
Drug Therapy
1
Blotting, Western
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Chondrosarcoma, Extraskeletal Myxoid
×
Dacarbazine
×
Clear all
No trials found.